Absolute oral bioavailability and pharmacokinetics of canagliflozin: A microdose study in healthy participants

E-ISSN： 2160-7648|4|4|295-304

ISSN： 2160-763X

Source： Clinical Pharmacology In Drug Development, Vol.4, Iss.4, 2015-07, pp. : 295-304

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of canagliflozin on the pharmacokinetics of glyburide, metformin, and simvastatin in healthy participants

Clinical Pharmacology In Drug Development, Vol. 4, Iss. 3, 2015-03 ,pp. : 226-236

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetics and bioavailability of pentoxifylline in healthy volunteers-a comparative study of three oral formulations

By Pokrajac M. Miljkovic B. Simic D. Brzakovic B. Galetin A.

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 43, Iss. 2, 1997-04 ,pp. : 193-196

Elsevier

Access to resources Recommend Favorite

Effect of food on the pharmacokinetics of canagliflozin, a sodium glucose co‐transporter 2 inhibitor, and assessment of dose proportionality in healthy participants

Clinical Pharmacology In Drug Development, Vol. 4, Iss. 4, 2015-07 ,pp. : 279-286

John Wiley & Sons Inc

Access to resources Recommend Favorite

Vinflunine Oral Pharmacokinetics and Absolute Bioavailability of Soft and Hard Gelatin Capsules: Results of Two Phase I Trials

By Delord Jean-Pierre

Clinical Pharmacokinetics, Vol. 51, Iss. 6, 2012-06 ,pp. : 357-364

Adis International

Access to resources Recommend Favorite

The Absolute Oral Bioavailability and Population-Based Pharmacokinetic Modelling of a Novel Dipeptidylpeptidase-IV Inhibitor, Vildagliptin, in Healthy Volunteers

By He Yan-Ling

Clinical Pharmacokinetics, Vol. 46, Iss. 9, 2007-01 ,pp. : 787-802

Adis International

Access to resources Recommend Favorite